Northern Trust’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,357
| Closed | -$150K | – | 4468 |
|
|
2025
Q1 | $150K | Buy |
16,357
+2,272
| +16% | +$14.3K | ﹤0.01% | 4021 |
|
|
2024
Q4 | $94.1K | Sell |
14,085
-2,819
| -17% | -$24.8K | ﹤0.01% | 4165 |
|
|
2024
Q3 | $170K | Sell |
16,904
-25,638
| -60% | -$374K | ﹤0.01% | 3929 |
|
|
2024
Q2 | $664K | Buy |
42,542
+1,182
| +3% | +$19.8K | ﹤0.01% | 3401 |
|
|
2024
Q1 | $906K | Buy |
41,360
+341
| +0.8% | +$7.57K | ﹤0.01% | 3355 |
|
|
2023
Q4 | $794K | Buy |
41,019
+159
| +0.4% | +$2.9K | ﹤0.01% | 3390 |
|
|
2023
Q3 | $754K | Buy |
40,860
+1,383
| +4% | +$24.9K | ﹤0.01% | 3384 |
|
|
2023
Q2 | $728K | Buy |
39,477
+31,918
| +422% | +$755K | ﹤0.01% | 3447 |
|
|
2023
Q1 | $219K | Buy |
7,559
+618
| +9% | +$16.5K | ﹤0.01% | 3819 |
|
|
2022
Q4 | $193K | Hold |
6,941
| – | – | ﹤0.01% | 3888 |
|
|
2022
Q3 | $381K | Sell |
6,941
-625
| -8% | -$34.3K | ﹤0.01% | 3603 |
|
|
2022
Q2 | $415K | Buy |
7,566
+101
| +1% | +$3.71K | ﹤0.01% | 3603 |
|
|
2022
Q1 | $277K | Buy |
7,465
+3,046
| +69% | +$109K | ﹤0.01% | 3988 |
|
|
2021
Q4 | $108K | Hold |
4,419
| – | – | ﹤0.01% | 4395 |
|
|
2021
Q3 | $199K | Sell |
4,419
-112
| -2% | -$4.7K | ﹤0.01% | 4182 |
|
|
2021
Q2 | $211K | Sell |
4,531
-20,495
| -82% | -$1.05M | ﹤0.01% | 4149 |
|
|
2021
Q1 | $1.39M | Sell |
25,026
-823
| -3% | -$50.1K | ﹤0.01% | 3444 |
|
|
2020
Q4 | $1.6M | Buy |
25,849
+219
| +0.9% | +$13.4K | ﹤0.01% | 3301 |
|
|
2020
Q3 | $1.5M | Buy |
25,630
+1,063
| +4% | +$78.7K | ﹤0.01% | 3200 |
|
|
2020
Q2 | $2.74M | Buy |
24,567
+2,268
| +10% | +$161K | ﹤0.01% | 2858 |
|
|
2020
Q1 | $1.5M | Buy |
22,299
+2,075
| +10% | +$209K | ﹤0.01% | 3013 |
|
|
2019
Q4 | $2.8M | Buy |
20,224
+1,005
| +5% | +$130K | ﹤0.01% | 2923 |
|
|
2019
Q3 | $2.02M | Buy |
19,219
+4,039
| +27% | +$403K | ﹤0.01% | 3102 |
|
|
2019
Q2 | $1.61M | Buy |
15,180
+120
| +0.8% | +$15.8K | ﹤0.01% | 3175 |
|
|
2019
Q1 | $2.33M | Sell |
15,060
-585
| -4% | -$67.8K | ﹤0.01% | 2982 |
|
|
2018
Q4 | $1.46M | Sell |
15,645
-86
| -0.5% | -$12.3K | ﹤0.01% | 3215 |
|
|
2018
Q3 | $2.93M | Buy |
15,731
+3,213
| +26% | +$916K | ﹤0.01% | 2997 |
|
|
2018
Q2 | $5.25M | Buy |
12,518
+7,247
| +137% | +$2.44M | ﹤0.01% | 2658 |
|
|
2018
Q1 | $1.58M | Buy |
5,271
+283
| +6% | +$78.4K | ﹤0.01% | 3224 |
|
|
2017
Q4 | $1.41M | Buy |
+4,988
| New | +$1.4M | ﹤0.01% | 3294 |
|
Northern Trust's OPTN Position: Q2 2025 in Review
Northern Trust sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 16,357 shares — an estimated $150K sold.
Northern Trust first reported a position in OPTN in Q4 2017 and held it in 30 quarters. The position peaked at $5.25M in Q2 2018. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- Northern Trust reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- Northern Trust sold 16,357 OptiNose shares in Q2 2025, an estimated $150K.
- Northern Trust first reported a position in OptiNose in Q4 2017 and held it in 30 quarters.
- Northern Trust's OptiNose position peaked at $5.25M in Q2 2018.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.